Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives

Details for Australian Patent Application No. 2005230897 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Humphrey, Guy R.; Tellers, David M.

Agent Spruson & Ferguson

Pub. Number AU-B-2005230897

PCT Pub. Number WO2005/097745

Priority 60/558,972 02.04.04 US

Filing date 29 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 3 March 2011

International Classifications

C07B 53/00 (2006.01) Asymmetric syntheses

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/94 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097745 Priority application(s): WO2005/097745

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

3 March 2011 Application Accepted

  Published as AU-B-2005230897

30 June 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230899-Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS)

2005230896-Synthesis of pyrrole-2-carbonitriles